Prolacta
4 known investors
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units. The company's products are used to support nutrition and reduce complications in extremely premature infants globally.
BiotechHealthtechMedical Devices
Investors · 4
In the news
- The Prolacta Bioscience Foundation Empowers Parents and Communities With Over Half a Million Dollars in Grant Funding in 2022prnewswire.com · 2023
- Prolacta Bioscience - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Prolacta Bioscience(R) Raises $35 Million in Mezzanine Financingfinance.yahoo.com · 2016
- UPDATE - Prolacta Bioscience(R) Raises $35 Million in Mezzanine Financingglobenewswire.com · 2016
- Prolacta Bioscience Raises Series D funding from Health Evolution Partners - FinSMEsfinsmes.com · 2011
- Prolacta Raises $12 Million | PE Hubpehub.com · 2007